Skip to research
Margin Monkey THEMARGINMONKEY Start my free trialTry free

GoodRx (GDRX) stock in plain English

Free brief · no signupStart here
GDRXPublished Nov 13, 2026
GoodRx Holdings Inc
Healthcare · Health Information Services
Operates a digital platform that provides prescription drug discount cards and comparison pricing tools.
Assets:
70,000+ partner pharmaciesNetwork covers major retail chains and independents across the United States
20 million consumers servedMaintains proprietary pricing datasets across retail prescription markets
Employer Direct programDelivers structured coverage solutions for weight loss and GLP-1 treatments
Locked assetIn the full report
Rated Nov 19, 2026

Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.

37
OPS ScoreOperating finances
Latest quote
-10.12%$3.02
$1.03B
64.1×
$786.46M

Change shown by the quote provider. Data may be delayed.

Financial statements, in plain wordsSales, profit, debt and cash, year by year
Published Nov 13, 2026Quotes updated Nov 20, 04:10 UTCOPS Score, TMM Score and the rating are research summaries, not advice or forecasts.
That was GDRX. The desk has 1,900+ more companies.Each one comes with its scores, its flags and the sources behind them.
7 days free · No card

What does GoodRx (GDRX) do?

GoodRx Holdings Inc (GDRX) is a U.S.-listed company in Healthcare (Health Information Services). What it does: Operates a digital platform that provides prescription drug discount cards and comparison pricing tools. Aggregates prescription drug prices across tens of thousands of pharmacies to offer digital discount coupons. It is worth $1.03B on the market and sold $786.46M over the last year.

Market cap
$1.03B
P/E ratio
64.1×
Annual sales
$786.46M
Sector
Healthcare
Industry
Health Information Services
Brief updated
Nov 13, 2026

Brands and businesses behind GDRX

  • VitaCare: Provides digital pharmacy services that help patients access and afford specialized therapies through manufacturer copay programs.

GDRX’s flags, in plain English

Each flag is a number from GoodRx’s reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 13, 2026.

Wide Gross Margin

Gross margin of 79.5% after the cost of making its products. There is a large gap between what its products cost to make and what they sell for, and that gap pays for everything else.

Cheap on Cash Flow

Priced at 5.2 times the cash it generates each year. The share price is low compared with the cash the business actually brings in, and cash is harder to dress up than profit.

Insiders Hold

Insiders own 74.2% of the company. The people who run the company own a meaningful slice of it, so they gain or lose along with other shareholders.

Priced for Perfection

Priced at 64.1 times its yearly profit, so a lot of growth is already expected. The share price already assumes strong results, so news that is merely good can still send it down.

1 more risk note open with the free trial. Try it free for 7 days.

Questions about GDRX

How big is GoodRx?

GoodRx’s market cap is $1.03B: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $786.46M: what customers paid the company over the last year, before any costs.

What is GDRX’s P/E ratio?

GDRX’s P/E ratio is 64.1×. Investors pay about 64.1 dollars for each dollar of the company’s yearly profit. A low number can mean a bargain or a problem, so read it next to the flags.

What could go wrong with GDRX?

A pending thirty-two million dollar data privacy class action settlement creates immediate administrative costs and legal exposure. That is one risk on GoodRx’s card. Its first risk flag is Priced for Perfection, explained above. The card holds 1 more risk note for trial accounts. A flag reads what the company reported. It does not predict the price.

Where do these numbers come from?

From GoodRx’s own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. GDRX’s filings on SEC.gov. The Margin Monkey is research, not advice.

Your first 7 days are free.Search all 1,900+ companies and open every card. Members also get the ratings, Picks and the TMM Score.
7 days free · No card